Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON52106
NL-OMON52106
Completed
Phase 4

Prospective monitoring of immune response following COVID-19 vaccination in children with cancer - VACCinATE

Prinses Máxima Centrum voor Kinderoncologie0 sites130 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Prinses Máxima Centrum voor Kinderoncologie
Enrollment
130
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Prinses Máxima Centrum voor Kinderoncologie

Eligibility Criteria

Inclusion Criteria

  • •\-Willing to receive routine COVID\-19 vaccination with Pfizer or Moderna vaccine
  • •as part of the national vaccination program (cohort I)
  • •\-Having received SARS\-CoV\-2 vaccination with Pfizer or Moderna as part of the
  • •national vaccination program, with the last vaccination less than 6 weeks
  • •before study entry (Cohort II \+ cohort III \+ cohort IV)
  • •\-Written informed consent

Exclusion Criteria

  • •\-History of severe adverse reaction associated with a vaccine and/or severe
  • •allergic reaction (e.g. anaphylaxis) to any component of the study
  • •intervention(s).
  • •\-Not able to give informed consent (eg language problem, illiteracy)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
Monitoring response on COVID-19 vaccination in children with cancerChildren with cancer, receiving COVID-19 vaccinationTherapeutic area: Body processes [G] - Immune system processes [G12]
EUCTR2021-003388-90-NLPrincess Máxima Center for Pediatric Oncology130
Active, Not Recruiting
Phase 1
Effectivity of COVID-19 vaccination in people with Down syndrome
EUCTR2021-002613-34-NLniversity Medical Center Utrecht640
Recruiting
Phase 4
Prospective monitoring of antibody response following COVID-19 vaccination in patients with Down syndrome
NL-OMON54387niversitair Medisch Centrum Utrecht640
Completed
Phase 4
Immune response following COVID-19 vaccination in children with cancer<tr><td>Childhood cancer, Corona vaccination, immune response</td></tr>Childhood cancer, Corona vaccination, immune response10047438
NL-OMON21465Princess Máxima Center for Pediatric Oncology130
Recruiting
N/A
Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.Breastcancermammacarcinoma10006291
NL-OMON36250Antoni van Leeuwenhoek Ziekenhuis20